How Technological Advancements are Fueling US Cell Viability Assays Market Growth
The US cell viability assays market is on a trajectory of remarkable expansion, projected to achieve a valuation of approximately USD 1,535.6 million by 2035, up from USD 625.84 million in 2024. This growth, marked by a robust CAGR of 8.5%, underscores a significant shift in the landscape of biomedical research and drug development. The technological advancements in assay methodologies are...
0 Comments 0 Shares 8 Views 0 Reviews